Introduction {#S0001}
============

Foodborne illness resulting from food contamination by pathogenic bacteria such as *Bacillus cereus* (*B. cereus*),[@CIT0001] *Staphylococcus aureus* (*S. aureus*),[@CIT0002] *Salmonella typhimurium* (*S. typhimurium*),[@CIT0003] and *Escherichia coli* (*E. coli*)[@CIT0004] is considered a global health concern.[@CIT0005] Cancer involves abnormal cell division, which is also a global problem that poses a great threat to human health.[@CIT0006] Recent statistics has shown that mortality due to breast cancer accounts for 30% of all recent cancers among women in 2018.[@CIT0007] Moreover, evidence has demonstrated the link between oxidative stress and cancer development.[@CIT0008] One of the challenges in cancer treatment is finding a method of diagnosis and treatment that is effective and target specific.[@CIT0008] This represents a major drawback in the diagnosis and treatment of cancer and other diseases and has led to the development of nanomedicine an area of nanotechnology involving the manipulation of matter within the nanoscale range of 1--100 nm at 10^−9^ dimension.[@CIT0009] The medical applications of nanotechnology involve the use of both chemical and physical methods for the synthesis of organic and inorganic nanoparticles that are biocompatible for transporting drugs with high target specificity.[@CIT0008] Nanoparticles are capable of improving drug permeation across cell membranes[@CIT0010] and controlling the release of the encapsulated drug.[@CIT0009] Chitosan is currently being explored due to its unique properties as a nanocarrier for the delivery of antimicrobial, anticancer and antioxidative agents of natural origin, such as plant essential oils (EOs).[@CIT0008]--[@CIT0011] *Ocimum gratissimum* (OG) is a herbaceous plant belonging to the *Lamiaceae* family. This plant is indigenous to tropical, savanna and coastal areas. OG flowers and leaves have been used in the traditional treatment of bacterial infections, fevers and colds, as well as in the preparation of infusions due to its EO richness.[@CIT0012] EOs are hydrophobic liquids that are volatile in nature and have a distinct odour. They are composed of several bioactive components, such as phenols, terpenes, flavonols, sterols, terpenoids, and several aromatic compounds.[@CIT0005] However, notwithstanding the increased applicability of plant EOs in diverse food, medical and pharmaceutical sectors, their lipophilic nature, unstable mixes, sensitivity to diverse environmental condition (oxygen, pressure, chemicals, light, and heat) and short effect overtime constrain their use in food and medical applications.[@CIT0011]--[@CIT0013] Hence, it is currently believed that the nano-encapsulation of EOs using polymeric substances such chitosan will surmount the above challenges. Nano-encapsulation does not only protect the EOs' bioactive components from degradation due to contact with unfavourable environmental conditions but also leads to the synthesis of novel materials with distinct material properties at the nanoscale.[@CIT0014]

Chitosan (CS) is a linear cationic polysaccharide that is obtained by the partial deacetylation of chitin, the second most abundant polysaccharide.[@CIT0015]--[@CIT0017] Structurally, CS consists of β-(1-4) *N*-acetyl-d-glucosamine and β-(1,4)-2-amino-2-deoxy-D-glucopyranose units.[@CIT0018] Previous studies have demonstrated the applications of CS in the field of medicine and pharmaceutical research due to their mucoadhesive properties as well as their antibacterial, anticancer and permeation-enhancing ability for targeted drug and protein delivery.[@CIT0017],[@CIT0019] Notably, a composite of CS with other polymeric material has proven useful in regenerative medicine.[@CIT0020] However, one drawback in the applicability of CS is the poor solubility at neutral and alkaline conditions, which decreases drug delivery efficiency at pH values above 6.[@CIT0021] This led to the synthesis of N, N, N-trimethyl chitosan (TMC), a quaternised derivative of CS that is soluble at different pH and has improved biological and physiological properties including immunostimulatory ability, high stability, non-toxicity, high charge density and biodegradability.[@CIT0015]--[@CIT0019] TMC has shown a potential use as an adjuvant and in gene delivery due to its ability to form polyplexes with DNA.[@CIT0017],[@CIT0022]

The aim of this study is to propose a novel approach for the optimised synthesis of *Ocimum gratissimum* essential oil (OGEO)-loaded nanoparticles with distinct physiochemical properties. Also, to the best of our knowledge, the bioactivities and in vitro release kinetic pattern of OGEO-encapsulated CS and TMC nanoparticles at varying physiological pH conditions (pH 3 and pH 7.4) have not been elucidated in the literature to date. In this context, OGEO encapsulation in CS and TMC nanostructures, its subsequent in vitro release kinetic pattern and their bioactivities as anticancer, antibacterial and antioxidant agents form the primary basis of this study.

Materials And Methods {#S0002}
=====================

Materials {#S0002-S2001}
---------

Chitosan (90% deacetylation, 150,000 Da), potassium iodide, sodium chloride, sodium triphosphate pentabasic (TPP), 1,1-diphenyl-2-picrylhydrazyl (DPPH), Mueller-Hinton agar (MHA), Mueller-Hinton Broth (MHB), Folin-Ciocalteu reagent, sodium carbonate, ciprofloxacin, tween 80 and chloramphenicol were purchased from Sigma-Aldrich, USA. Iodomethane, sodium hydroxide, *N*-methyl-2-pyrrolidone, acetone, acetic acid, ethanol, hydrochloric acid, methanol, Dulbecco's modified eagle's medium (DMEM) and phosphate-buffered saline (PBS) were purchased from Merck, Germany.

Extraction Of O. Gratissimum EOs And Methanolic Extract {#S0002-S2002}
-------------------------------------------------------

The extraction of *O. gratissimum* EOs and the methanolic extract was performed as defined by Grbic-Ljaljevic et al and Pavithra et al, respectively, with little modification.[@CIT0023],[@CIT0024] For EO extraction, 100 g of the pulverised leaves were subjected to hydrodistillation with H~2~O (800 mL) for 4 h in a Clevenger apparatus. Anhydrous sodium sulphate was used to remove excess water from the crude EO. For the methanolic extract, lipid degradation using the Soxhlet method using pure methanol (250 mL) was adopted. The extracts were recovered using a rotary evaporator (Heidolph 3600127, Heidolph^TM^ Germany). The crude extract was lyophilised with a freeze dryer and stored in a desiccator at 4 °C until use.

GC-MS Analysis Of O. Gratissimum Essential Oils And Methanolic Extract {#S0002-S2003}
----------------------------------------------------------------------

The GC-MS (GCMS-QP2010 SE, Shimadzu, Japan) was used to analyse the biochemical constituents of the *O. gratissimum* EOs and methanolic extracts as prescribed by Gasparetto et al, with few modifications.[@CIT0003] The qualitative analysis was performed with a fused silica capillary column (HP-5Ms, 30×0.25, 0.25 µm, film thickness) using helium (flow-rate, 1 mL min^−1^). The oven temperature was set at 40 °C and held for 5 mins, then increased to reach 270 °C at a rate of 3 °C/min with a split ratio of 60:1. A temperature of 180 °C was set for the ion sources and connection parts, and the MS was operated using an interface temperature of 240 °C. Electron impact (EI) mode and 70 eV ionisation energy were used. The delay time for MS prior to scanning was 5 mins. Samples were run fully at a range of 50 to 650 m/z. OGEO and OG-MeOH component identification were performed by comparing retention indices and matching the recorded mass spectra of each compound with the Willey MS libraries and NIST 14 mass spectral library of chemicals.

Total Phenolic Content Determination {#S0002-S2004}
------------------------------------

The Folin-Ciocalteu method as described by Shahidi and Zhong was adopted in the determination of total phenolic content (TPC) of OGEO and OG-MeOH, with slight modification.[@CIT0025] Briefly, 500 µL of Folin-Ciocalteu reagent (1 % v/v) was added to 100 µL of the OGEO and OG-MeOH (0.5 mg mL^−1^) and then gently mixed and allowed to stand for 5 min. Then, 400 µL of Na~2~CO~3~ (20% w/w) was added to the mixture followed by incubation in dark conditions at 25 °C. A UV-visible spectrophotometer (UV-2450, Shimadzu, Japan) was used to measure the absorbance of the samples at 765 nm against a distilled water blank. Gallic acid standards were used for the calibration curve. The linear regression of the garlic acid standard curve was used to determine the TPC of the samples, with results being expressed as milligrams of garlic acid equivalent per gram dry weight of plant extracts (mg GAE/g). Experiments were repeated at least three times (n ≥ 3).

Preparation Of Chitosan And N, N, N-Trimethyl Chitosan Nanoparticles {#S0002-S2005}
--------------------------------------------------------------------

### Synthesis Of N, N, N-Trimethyl Chitosan Polymer {#S0002-S2005-S3001}

The initial step for TMC polymer synthesis involves the methylation of CS, while the subsequent phase involves TMC nanoparticle synthesis with the obtained TMC polymer. A diagrammatic representation describing the procedural steps of TMC polymer synthesis is shown in [Figure 1](#F0001){ref-type="fig"}. Briefly, 5.75 mL of iodomethane, 40 mL of 1-methylpyrrolidin-2-one, 1 g of CS, and 2.4 g of potassium iodide were mixed with 5.5 mL sodium hydroxide (15%) until a clear solution was formed. The solution was heated at 60 °C for 6 h using a Liebig condenser. Upon cooling to room temperature, acetone was used to isolate the product after centrifugation. The exchange of I^−^ with Cl^−^ was achieved by dissolving the product in NaCl (5.0%, w/w) solution. The product was recovered with acetone and dried to obtain a white powder. Figure 1Schematic illustration of chitosan methylation for the synthesis of trimethyl chitosan polymer.**Abbreviations:** NaOH, sodium hydroxide; CH~3~I, Methyl iodide; C~5~H~9~NO, N-Methyl-2-pyrrolidone; KI, Potassium iodide; C~3~H~6~O, acetone; NaCl, Sodium chloride.

### Optimised Loading Of OGEO Into Chitosan And N, N, N-Trimethyl Chitosan Nanoparticles {#S0002-S2005-S3002}

Optimisation techniques involving different percentage concentrations of TMC, CS, OGEO, TPP, rotation per minute (rpm) and stirring time (min) were adopted in other to select the best method to create the optimal particle size, as determined by the Zetasizer (Zetasizer Nano ZS, Malvern Panalytical, UK). A graphical illustration for the optimised synthesis of OGEO-loaded chitosan and N, N, N-trimethyl chitosan nanoparticle is presented in [Figure 2](#F0002){ref-type="fig"}. Briefly, TMC and CS solutions of 0.25%, 0.5% and 1% (w/v) were suspended in H~2~O (pH 5.2) and acetic acid (1% v/v), respectively, and stirred for 24 h. The CS and TMC suspension was filtered with a Millipore filter (0.65 µm). OGEO (0.25, 0.5 and 1 g) was then slowly added to the CS and TMC solution (40 mL) and maintained at a pH of 4.5. Homogenisation of the solution was performed at different revolution per minute (rpm) rates (5000, 10,000 and 15,000). Furthermore, different concentrations of TPP (0.1%, 0.4%, 0.7%, 1% and 1.5% (w/v) were added to the mixtures, which served as the crosslinker. The mixture was further stirred for different revolution times (15, 30, 45 and 60 min). Nanoparticles were then collected by centrifuging at 4 °C for 30 min at 6000 rpm. The synthesised nanoparticles were stored at 4 °C prior to further analysis. Figure 2Process illustration for the optimised synthesis of *Ocimum gratissimum* essential oil-loaded chitosan and *N, N, N* chitosan nanoparticles.**Abbreviation:** TTP, tripolyphosphate.

Characterisation Of Synthesised Nanoparticles {#S0002-S2006}
---------------------------------------------

### Molecular Characterisation By Fourier-Transform Infrared Spectroscopy (FT-IR) {#S0002-S2006-S3001}

OGEO, TMCNP, CSNP, OGEO-CSNP and OGEO-TMCNP FTIR spectra were analysed at a wavelength range of 4000--400 cm^−1^ with an FTIR spectrophotometer (IR Prestige-21, Shimadzu, Japan).

### Morphological Characterisation Of Synthesised Nanoparticles {#S0002-S2006-S3002}

The particle morphology of both encapsulated and non-encapsulated EOs was examined using scanning electron microscopy (SEM) (JSM-6610LV, JEOL, Japan). The samples (TMCNPs, CSNPs, OGEO-TMCNPs and OGEO-CSNPs) were made to settle on aluminium stubs with two-fold adhesive tape and were vacuum covered with a thin gold coating prior to examination under 500 x magnification at a voltage acceleration of 20 Kv.

### Nanoparticle Diameter, Zeta Potential, And Polydispersity Index (PDI) {#S0002-S2006-S3003}

The particle size and zeta potential of the resultant nanoparticles synthesised using different optimisation techniques were measured using a size and zeta potential analyser (Zetasizer Nano ZS, Malvern Panalytical, UK). The measurements were taken at least three times (n ≥ 3) and the average values were recorded.

Determination Of Nanoparticle Loading Capacity (LC) And Encapsulation Efficiency (EE) {#S0002-S2007}
-------------------------------------------------------------------------------------

The nanoparticle loading capacity and encapsulation efficiency were determined as follows, 100 mg of CSNPs and TMCNPs loaded with OGEO was added to HCl solution (4 mL, 1M) and placed in a boiling water bath for 30 min to dissolve nanoparticles, followed by the addition of 2 mL of 100% ethanol into the mixture and centrifugation for 5 min at 9000 rpm and 25 °C.[@CIT0026] The amount of OGEO in the supernatant was 250--400 nm, as measured by a UV-visible spectrophotometer (UV-2450, Shimadzu, Japan). The maximum recorded absorption was 285 nm.

Free OGEO (5--50 mg mL^−1^) calibration curves were used to determine the amount of OGEO release. [Equations 1](#M0001) and [2](#M0002) were used to calculate the LC and EE, respectively.[@CIT0027] $$\documentclass[12pt]{minimal}
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In Vitro Studies {#S0002-S2008}
----------------

### Kinetic Modelling For The In Vitro Release Of O. Gratissimum EOs {#S0002-S2008-S3001}

The in vitro drug release kinetics of OGEO from CSNPs and TMCNPs were ascertained by membrane dialysis, as proposed by Shetta et al, with few modifications.[@CIT0005] Separately, 2 mg of the nanoparticles were suspended in 5 mL PBS (0.1 M, 1% Tween-80) of solutions with different physiological pH values (3.0 and 7.4). Physiological pH values of 3.0 and 7.4 were selected due to the pH considerations of the gastrointestinal tract and the pH of the cancer cells tested. The suspension was placed in a shaking water bath (GFL-1083, thermolab, India) maintained at 37 °C ± 0.5 and stirred at 100 rpm. Samples were withdrawn at predetermined time intervals (5, 10, 15, 30, 45, 60 min, and subsequently every 1 h until 24 h). The volume of the withdrawn sample was replaced with PBS solution to maintain a constant volume. Absorbance values of the release OGEO were analysed by a UV-visible spectrophotometer (UV-2450, Shimadzu, Japan) at 270 nm (maximum absorbance wavelength for OGEO in PBS medium). By using the calibration curve, the OGEO concentration in the withdrawn medium was determined. The calibration curve (n ≥ 3) consisted of OGEO concentrations prepared with dissolution media ranging from 0.00025 to 0.08 mg mL^−1^. Different kinetic models (namely the zero-order model, first-order model, Higuchi model, and Korsmeyer--Peppas kinetic model [Equations (3](#M0003))--([6](#M0006)), respectively) were adapted in order to ascertain the EO rate-controlling processes and release mechanism in vitro. All release experiments were conducted in triplicate (at minimum; n ≥ 3). $$\documentclass[12pt]{minimal}
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Where F is the amount of EO released at time t; and K~0~, K~1~, K~h~ and K~kp~ are the zero-order, first-order, Higuchi and Korsmeyer-Peppas release rate constants, respectively. Subsequently, the most suitable EO release mechanism among the kinetic models was obtained.

### Antioxidant Activity Assay {#S0002-S2008-S3002}

The 2, 2-diphenyl-1-picrylhydrazyl (DPPH) scavenging properties of the nanoparticles and OGEO and OG-MeOH extract were examined according to the method proposed by Rakmai et al, with few modifications.[@CIT0028] Briefly, 2 mL of ethanolic solution of DPPH (180 µmol L^−1^) was added to OGEO (0.1 mg mL^−1^), OG-MeOH (0.1 mg mL^−1^), while 0.2 mg mL^−1^ was added for the respective nanoparticles. The solutions were kept in the dark at room temperature. The absorbance of the sample was measured at 517 nm at varying time intervals by a UV-visible spectrophotometer (UV-2450, Shimadzu, Japan). Each test was run in triplicate (at minimum; n ≥ 3). The percentage of DPPH scavenging activity was established using the following equation: $$\documentclass[12pt]{minimal}
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\end{document}$$

Where:

A sample = sample + DPPH

A blank = sample only

A control = absorbance of DPPH

### Antibacterial Activity {#S0002-S2008-S3003}

Suspensions of two strains of Gram-positive bacteria (*Staphylococcus aureus* (ATCC25923), *Bacillus cereus* (ATCCI4579)) and Gram-negative bacteria (*Escherichia coli* (ATCC8739), *Salmonella typhimurium* (ATCC 13311)) were adjusted to the McFarland standard (1.5×10^8^ CFU mL^−1^) and spread in an MHA using sterile cotton swabs. Subsequently, the prepared membrane disc was impregnated with the samples (OGEO, OG-MeOH, CSNPs, TMCNPs, OGEO-CSNPs and OGEO-TMCNPs) at respective maximum bactericidal drug concentration (MBC) values of 150, 150, 200, 100, 60 and 40 (mg mL^−1^) and placed on the microbial culture plates. For the positive control, chloramphenicol and ampicillin were used. All plates were incubated at 37 °C for 24 h. Inhibition zones were measured (in mm) to determine the antibacterial activity of the samples.[@CIT0029] Experiments were conducted at least three times (n ≥ 3).

### Proliferation And Cytotoxicity Assay {#S0002-S2008-S3004}

The cytotoxicity of OGEO, MeOH, CSNP, TMCNP, OGEO-CSNP and OGEO-TMCNP samples on MDA-MB-231 cells was evaluated by trypan blue dye exclusion assays. The use of cell lines was approved by Biotechnology Research Centre Ethical Committee (BRCEC2011-01). Briefly, cells were plated in 35 mm dishes (3 × 10^4^ mL^−1^ density) and incubated for 24 h prior to treatment with the different concentration (0--100 µg mL^−1^) of OGEO, OG-MeOH, free nanoparticles and OGEO-loaded nanoparticles. After treatment, cells were incubated for 48 h. Then, 1 mL DMEM was used for the control group. Meanwhile, 4 % trypan blue dye was added into the cell culture dishes after the 48-h treatment and incubated for 10 min. The culture plates were viewed from 30 randomly selected sites using an inverted microscope (Leica DFC295, Leica microsystem, Germany) to determine the cell viability count (%). Then, 3-\[4, 5-dimethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide (MTT) assays were also adapted to determine the antiproliferation activity of OGEO, OG-MeOH, and the nanoparticles. Briefly, cells were seeded into 96-well plates at approximately 10^4^ cells per well and grown for 24 h. Thereafter, different doses (0--100 µg mL^−1^) of OGEO, OG-MeOH, free nanoparticles and OGEO-loaded nanoparticles were added. Supernatants were discarded after the 24-h incubation period. Then, 10 μL MTT (5 mg mL^−1^) was added and incubated for 4 h at 37 °C. Formazan crystals were then dissolved with 100 μL of DMSO. The absorbance was read with a multimode microplate reader at 570 nm. All experiments were performed in triplicate (at minimum) and repeated for three experiments (n = 3). The percentage of cell viability was calculated using the following equation: $$\documentclass[12pt]{minimal}
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Statistical Evaluation {#S0002-S2009}
----------------------

All experiments were repeated multiple times (n ≥ 3) and statistical comparisons were expressed using one-way analysis of variance (ANOVA) followed by a Student's two-tailed *t*-test, where necessary. Mean difference was considered non-significant at *P* \> 0.05, significant at *P* ≤ 0.05 and very significant at *P* ≤ 0.0001. Statistical computation and analyses were performed using the SPSS program (SPSS version 23, SPSS Inc.). Graphical representations of results were created with OriginPro (version 2016).

Results And Discussion {#S0003}
======================

Chemical Composition Analysis Of O. Gratissimum EOs And Methanolic Extract {#S0003-S2001}
--------------------------------------------------------------------------

The percentage chemical composition of *O. gratissimum* essential oils (EOs) and methanolic extracts were obtained from the GC-MS as peak area vs. retention time ([Figure 3A](#F0003){ref-type="fig"} and [B](#F0003){ref-type="fig"}). A total of 19 compounds were identified for OGEO ([Table 1](#T0001){ref-type="table"}), while 35 compounds were identified for OGEO-MeOH ([Table 2](#T0002){ref-type="table"}). The chemical composition results indicate that OGEO contains more hydrocarbons, monoterpenes, and acids. Newly observed compounds that were not previously reported for OGEO were identified, including eicosane, heneicosane, triphenylphosphine oxide, 1-acetyl-2methyl-2-cycloppentene, (E)-9-octadecenoic acid, 2-carene and gamma-terpinene. These new compounds might have been identified in this study due to the time of plant harvest, environmental factors, soil conditions, and plant age---all being factors that could affect the biochemical constituents of the plant extracts.[@CIT0030] While the identified compounds have known bioactivity, their applications are restricted due to their volatile nature. Hence, entrapment into polymeric matrices and a further reduction to nano sizes will surely increase their potential applications.[@CIT0012],[@CIT0013] Figure 3GC- MS chromatogram: (**A**) *O. gratissimum* essential oils and (**B**) methanolic extracts. Peak numbers refer to [Tables 1](#T0001){ref-type="table"} and [2](#T0002){ref-type="table"}, respectively. Table 1Major Chemical Composition Of *Ocimum Gratissimum* Essential Oils (%, Wt/wt) As Determined By Gas Chromatography-Mass SpectrometryComponentRetention Time (min)Content (%, wt/wt)Nature Of CompoundHexanoic acid1.0925.61Acid(E)-9-octadecenoic acid3.9213.54Acid7-Oxa-2-oxa-7-thiatricyclo\[4.4.0.0(3,8)\]decan-4-ol5.3758.21Fatty alcoholOxanamide5.9330.24EpoxideBicyclo\[3.1.0\]hex-2-ene, 4-methyl-1-(1-methylethyl)6.5045.82MonoterpeneBeta-myrcene7.8882.94Monoterpene2-carene8.4555.63HydrocarbonO-cymene8.6294.51HydrocarbonGamma-terpinene9.3842.43Monoterpene1-acetyl-2-methyl-2-cyclopentene10.0673.6KetoneAlpha-pinene12.5514.31TerpeneCis-ocimene12.82512.46MonoterpeneAlpha-terpinolene13.0250.73Terpeneα-caryophyllene13.22511.54SesquiterpeneThymol14.2071.49MonoterpenoidBeta-humulene17.9521.53SesquiterpeneHeneicosane29.4172.46HydrocarbonEicosane30.2926.14HydrocarbonTriphenylphosphine oxide32.2575.23Organophosphorus compound Table 2Chemical Composition Of *Ocimum Gratissimum* Methanolic Extract (%, Wt/wt) As Determined By Gas Chromatography-Mass SpectrometryChemical NameRetention Time (min)Content (%, wt/wt)Nature Of CompoundGlycerine3.3503.3Polyol compound1,2,3,4-butanetetrol3.4830.64Unknown*M*-cymene18.0503.9Hydrocarbon2-pentanoic acid, 4-hydroxy20.4000.63Alkyl carboxylic acidN-acetyl-proline29.8082.62ProlineTrans-(+)-carveol31.5420.53MonoterpenoidPhenol, 5-methyl-2-(1-methylethyl)- (CAS) Thymol32.7000.42Monoterpenoid phenolPhenol, 2-methyl-5-(1-methylethyl)- (CAS) Carvacrol32.9179.56Monoterpenoid phenolΒ-caryophyllene37.9504.21Sesquiterpene(E)-farnesene39.4671.02Sesquiterpene(+)-longifolene40.9250.79Tricyclic sesquiterpene(+)-aromadendrene41.2926.25Tricyclic hydrocarbonAlpha-cedrol42.2673.41Sesquiterpene alcoholGermacrene-d42.4580.13SesquiterpenePhenol, 2-(1,1-dimethylethyl)-6-methyl- (CAS) 6-tert-butyl-o-cresol44.0421.42Aromatic compoundAromadendrene epoxide-(ii)47.8750.76Sesquiterpenoid25,26-Dihydroxy-vitamin D352.6500.32Steroid9-eicosyne54.5330.67Terminal alkynes (hydrocarbon)Phytol55.3832.65Diterpene alcoholCitronellyl pentanoate55.7503.53Fatty alcohol esterPentadecanoic acid, 14-methyl-, methyl ester (CAS) methyl 14-methyl-pentadecanoate57.5753.46Fatty acid9-Octadecenoic acid (Z)- (CAS) Oleic acid59.3750.21Fatty acid1alpha,25-dihydroxy vitamin D3 (CAS) Calcitriol60.3425.78SteroidCholesteryl myristate61.6330.87Steroid esterKauren-18-ol, acetate, (4. beta.)- (CAS)63.1331.48Diterpenoids2-monolinolenin63.3421.49Fatty acylsEthyl linoleate65.0831.53EsterCholesterin palmitate65.6332.46EsterCycloeucalenone65.9330.14SteroidFlavone 4ʹ-oh,5-oh,7-di-o-glucoside66.9925.23FlavonoidAndrost-5-en-7-one, 3-(acetyloxy)-4,4-dimethyl-, (3.beta)- (CAS)67.3003.65Steroid esterSolanesol67.5927.32HydrocarbonTetracosapentaene, 2,6,10,15,19,23-hexamethyl- (CAS) Dihydrosqualene72.8004.87UnknownNerolidol72.9336.9Sesquiterpene1. 1H-3a,7-Methanoa1H-3a,7-Methanoazulen-6-ol, octahydro-3,6,8,8-tetramethyl-, \[3R-(3.alpha.,3a.beta.,6.alpha.,7.beta.,8a.alpha.)\]- (CAS) Cedrol73.5005.4Sesquiterpene alcohol

Total Phenolic Content {#S0003-S2002}
----------------------

Polyphenols are bioactive substances that are primarily associated with plants and essential oils in the human diet. A TPC determination is vital in order to ascertain the amount of antioxidants present in any plant. Dutta and Ray reported a positive correlation existing between phenolic and pharmacological activities such as antiviral, antimicrobial, anti-carcinogenic, anti-inflammatory and anti-allergic activities.[@CIT0031] The results of the TPC analysis ([Table 3](#T0003){ref-type="table"}) indicate that the TPC of OGEO was 11.7 ± 0.60 mg GAE/100 g, which is greater than (*P* \< 0.05) that of the OG-MeOH, which had a value of 1.4 ± 0.45 mg GAE/100 g. Primary sources of antioxidants, antiviral, antibacterial and anti-inflammatory activities include various compounds such as cyanine, flavonoids, flavones, flavonols and phenols.[@CIT0031],[@CIT0032] Variations in the antioxidant activity of plants could be the result of the varying phenolic hydroxyl groups and polyphenolic compounds of any given plant. A study by Santana et al (2014) discovered 20% and 90% phenolic content in *O. gratissimum* leaves and stems, respectively.[@CIT0033] Olamilosoye et al also noted the phenolic content of *O. gratissimum* leaves to be 90.03 GAE/100 g.[@CIT0034] Table 3Total Phenolic Content Of *O. Gratissimum* Essential Oils And Methanolic ExtractS/NCompoundTPC (mg GAE/100 g)1OGEO11.7 ± 0.60^a^2OG-MeOH1.4 ± 0.45^b^[^1]

Characterisation Of O. Gratissimum Free EOs And EO-Loaded Nanoparticles {#S0003-S2003}
-----------------------------------------------------------------------

### Molecular Interaction Of OGEO With CSNPs And TMCNPs {#S0003-S2003-S3001}

The IR spectra for the various constituent compounds of the nanoparticles are presented in [Figure 4](#F0004){ref-type="fig"}. The sharp peak at 1387 cm^−1^ for the OGEO-TMCNPs and TMCNPs was assigned to the asymmetrical stretching of C-H bonds of methyl groups existing in TMC.[@CIT0035]

The peak at 1635 cm^−1^ for both the CS and TMC nanoparticles was attributed to the C=O bonds of secondary amide groups related to the acetyl residues of TMC and CS nanoparticles.[@CIT0036] The band at 1402 cm^−1^ is assigned to the OH bend.[@CIT0037] The 2880 cm^−1^ band for the OGEO corresponded to methyl-CH stretch.[@CIT0010] The high intensity of the peak at 2880 for the OGEO-TMCNPs compared to the OGEO-CSNPs corresponds to an increase in the N-alkyl group as a result of N, N, N-trimethyl chitosan.[@CIT0038] Moreover, another band was identified at 1742 cm^−1^ for the OGEO, which is consigned to the methyne C-H stretch.[@CIT0011] The bands at 950 cm^−1^ and 918 cm^−1^ for OGEO correspond to the skeletal C-C vibrations.[@CIT0037] The successful encapsulation of OGEO into the TMCNPs and CSNPs is evident at 2880 cm^−1^ and 1089 cm^−1^, which are assigned to the methyl-CH stretch, NH bend and skeletal C-C vibrations, respectively.[@CIT0011] All four evaluated nanoparticles demonstrated the presence of CS, including OH, CH and NH stretch at 3000--3750 cm^−1^, and amides stretch at 1634 cm^−1^.[@CIT0010] The differences in the bend are due to the associations among chain segments of OGEO-CSNPs and OGEO-TMCNPs. The OGEO-loaded TMC nanoparticle spectra revealed the same peak as the free TMC nanoparticles, with the addition of extra peaks. Furthermore, an extra peak is also evident for the OGEO-loaded CS nanoparticles when compared to the free CS nanoparticles. Figure 4FTIR spectra of chitosan and N, N, N-trimethyl chitosan nanoparticles, free OGEO and OGEO-loaded nanoparticles.**Abbreviation:** FTIR, Fourier-transform infrared spectroscopy.

### Morphology Of OGEO-Loaded Nanoparticles {#S0003-S2003-S3002}

The SEM images revealed an increase in the size of the OGEO-loaded CSNPs compared to free CSNPs ([Figure 5A](#F0005){ref-type="fig"} and [B](#F0005){ref-type="fig"}). This is perhaps due to the encapsulation of the EOs into the nanoparticles' internal core. Woranuch and Yoksan likewise detailed an expansion in the size of nanoparticles due to the encapsulation of EOs.[@CIT0039] Notably, the surface of the TMCNPs appeared smoother compared to the OGEO-TMCNPS ([Figure 5C](#F0005){ref-type="fig"} and [D](#F0005){ref-type="fig"}), which could be the result of EOs becoming attached to the TMCNP surface.[@CIT0040] Malik et al also reported the smooth and irregular shape of antigen-loaded TMCNPs.[@CIT0022] The sizes of the OGEO-TMCNPs conformed to those reported by Sotelo-Boyás et al[@CIT0010]. According to Lai et al, the average size distribution of nanoparticles is a function of the method of nanoparticle synthesis and other experimental conditions.[@CIT0041] Figure 5SEM images: (**A**) free chitosan nanoparticles, (**B**) OGEO-loaded chitosan nanoparticles (**C**) free N, N, N-trimethyl chitosan nanoparticles and (**D**) OGEO-loaded N, N, N-trimethyl chitosan nanoparticles.**Abbreviations:** SEM, scanning electron microscope; OGEO, *Ocimum gratissimum* essential oils.

### Nanoparticles Diameter, Zeta Potential And Polydispersity Index (PDI) {#S0003-S2003-S3003}

The size distribution of nanoparticles containing OGEOs is presented in [Table 4](#T0004){ref-type="table"}. The results revealed that the polydispersity index, which is a measure of the uniformity in size distribution, were in an adequate range (0.256 *Đ* - 0.392 *Đ*). This demonstrates the uniformity, stability and monodispersity of the nanoparticles ([[Figure S1]{.ul}](https://www.dovepress.com/get_supplementary_file.php?f=220202.pdf)).[@CIT0042] According to results, free CSNPs had a smaller size (150.1±4.02 nm) compared to other formulations.Table 4Particle Diameter, Zeta Potential And Polydispersity Index (PDI) Of The Optimised OGEO-Loaded CS And TMC Synthesised NanoparticlesNanoparticlesZ-average\
Diameter±D\
(nm)PDI±DZeta Potential ±D (mV)Encapsulation Efficiency (%)CSNPs50.1±4.02^a^0.256 ±0.01^a^24.0±0.9^a^-TMCNPs84.3±6.51^b^0.312±0.09^b^19.2±0.1^b^-OGEO-CSNPs134.9±6.73^d^0.288±0.07^d^26.1±1.0^d^61.1±1.67OGEO-TMCNPs153.5±10.48^c^0.293±0.29^c^22.6±0.2^c^69.4±0.85[^2]

Zeta potential values for the nanoparticles were determined for CSNP~S~ (24.0±0.9), TMCNPs (19.2±0.1), OGEO-TMCNPs (22.6.293±0.2) and OGEO-CSNPs (26.10.288±1.0), respectively. Based on statistical analysis, the addition of EOs to the nanoparticles resulted in a significant increase (*P* \< 0.05) in the zeta potential values for OGEO-encapsulated nanoparticles. This conforms to the results of Zhang et al regarding increased zeta potential values resulting from drug loading.[@CIT0043] Although the zeta potential values determined for the nanoparticle were between 19--27 mV, the nanoparticles were stable with no form of aggregation. Furthermore, the percentage encapsulation efficiency (EE) of OGEO-CSNPs and OGEO-TMCNPs were within an acceptable range of 61.1±1.67% and 69.4±0.85%, respectively. Similar to a study by Li et al, the size of the synthesised nanoparticle in the present study has potential application in pharmaceutical and food industries.[@CIT0027]

Nanoparticle Encapsulation Efficiency (EE) And Loading Capacity (LC) {#S0003-S2004}
--------------------------------------------------------------------

The drug loading capacity and EE of the OGEO-loaded CS and TMC nanoparticles are presented in [Figure 6](#F0006){ref-type="fig"}. For OGEO-loaded CS nanoparticles, there was an upsurge in EE (42.54%) and LC (18.42%) among OGEO-CSNPs at an oil-CSNP ratio of 0.05:1 (w/w), as shown in [Figure 6A](#F0006){ref-type="fig"}. However, there was a drastic reduction in EE and LC for OGEO-CSNPs as oil ratio (w/w) increased. This can be as a result of the saturation of OGEO loading into chitosan nanoparticles. These findings are in line with a study by Yoksan et al[@CIT0044] For the OGEO-TMCNPs, the LC and EE were initially within the range of 27.71%, and 55.87% respectively. As OGEO amount increased, LC and EE decreased (see [Figure 6B](#F0006){ref-type="fig"}). In addition, Hossein et al reported a decrease in the EE and LC of CS nanoparticles as the concentration of essential oil increased.[@CIT0014] An increase in oil: CS weight ratio resulted in a significant difference for both the LC and EE (*P* \< 0.05). OGEO-TMCNPs had higher (*P* \< 0.05) EE and LC values with a corresponding increase in OGEO concentration compared to the OGEO-CSNPS. This indicates that the concentration of OGEO had a significant (*P* \< 0.05) effect on the EE and LC of the nanoparticles. This trend also conforms with other studies on the encapsulation of EOs with polymeric materials.[@CIT0010],[@CIT0045] Figure 6Loading capacity (LC) and encapsulation efficiency (EE): (**A**) *O. gratissimum* essential oil-loaded chitosan nanoparticles, (**B**) *O. gratissimum* essential oil-loaded N, N, N-trimethyl chitosan. Bars represent means ± standard deviation.**Abbreviations:** OGEO-CSNPs, *Ocimum gratissimum* essential oil-loaded chitosan nanoparticles; OGEO-TMCNPs, *Ocimum gratissimum* essential oil-loaded trimethyl chitosan nanoparticles.

In Vitro O. Gratissimum Essential Oil Release And Kinetic Modelling {#S0003-S2005}
-------------------------------------------------------------------

The effect of pH on essential oil release from the CS and TMC nanoparticles at an optimum EO to nanoparticle loading ratio (w/w) is shown in [Figure 7](#F0007){ref-type="fig"}. The release of OGEO from the nanoparticles was higher at pH 3.0 than at pH 7.4. This is as a result of the bulging of nanoparticles in acidic media, thereby leading to a higher EO release,[@CIT0046] with 64.19% and 48.45% cumulative EO release being observed for OGEO-TMCNPs and OGEO-CSNPs, respectively, at pH 7.4. At pH 3.0, cumulative EO release for OGEO-TMCNPs and OGEO-CSNPs were 77.35% and 70.39%, respectively. Malik et al reported a 30% protein release at pH 7.4 after 6 h with an increase to 55% within the first 24 h and reaching a steady state release after 48 h.[@CIT0022] OGEO-TMCNPs exhibited higher EO release at all pH conditions compared to the OGEO-CSNPs. This is the result of the increased EO loading capacity of TMC nanoparticles with the influence of the methyl group. In alkaline mediums, the chitosan amino group protonation increases the stability of the nanoparticles, thereby resulting in slower drug release.[@CIT0005] Also, there was a significant increase in the release rate of OGEO from the TMC nanoparticles over a longer time period, which might be due to a chemical interaction between OGEO and TMC functional groups. It should be noted that the release profiles of OGEO from the TMC nanoparticles were not complete; therefore, there is a need for the complete degradation of TMC nanoparticles.[@CIT0047],[@CIT0048] Moreover, the release of OGEO from the nanoparticles at all tested physiological pH can be regarded as a two-step biphasic process due to an initial burst release with a subsequent slower release.[@CIT0014] This type of release as expressed by Anitha et al is the result of the attachment of EO on the nanoparticles' surface.[@CIT0049]

The release profile of OGEO was applied to different kinetic models, including the zero-order, Korsmeyer--Peppas, first-order, and Higuchi models for different pH media (pH 3 and pH 7), as shown in [Figures 8](#F0008){ref-type="fig"} and [9](#F0009){ref-type="fig"}. As presented in [Table 5](#T0005){ref-type="table"}, the regression value for zero-order kinetics (r^2^) for both OGEO-loaded CS and TMC nanoparticles were moderate at all physiological pH conditions (0.557--0.799). This reveals that the drug release kinetic pattern is not well suited to the zero-order model. Also, for the Huguchi and first-order models, the r^2^ value was below 0.79 for OGEO-CSNPs and OGEO-TMCNPs at all pH ranges. The best r^2^ values were observed with the Korsmeyer-Peppas model for both OGEO-CSNPs and OGEO-TMCNPs in different pH media (pH 3.0 and pH 7.4). Figure 7Percentage cumulative in vitro release of *O. gratissimum* essential oils from chitosan and N, N, N- trimethyl chitosan nanoparticles: (**A**) pH 7.4 (**B**) pH 3.0. (Bars represent means ± standard deviation).**Abbreviations:** OGEO-CSNPs, *Ocimum gratissimum* essential oil-loaded chitosan nanoparticles; OGEO-TMCNPs, *Ocimum gratissimum* essential oil-loaded trimethyl chitosan nanoparticles. Figure 8Kinetic models for OGEO release from chitosan and N, N, N-trimethyl chitosan nanoparticles at pH 3 (**A**) Zero-order, (**B**) First-order, (**C**) Korsmeyer -- Peppas and (**D**) Higuchi model.**Abbreviations:** OGEO-CSNPs, *Ocimum gratissimum* essential oil-loaded chitosan nanoparticles; OGEO-TMCNPs, *Ocimum gratissimum* essential oil-loaded trimethyl chitosan nanoparticles. Figure 9Kinetic models for OGEO release from chitosan and N, N, N-trimethyl chitosan nanoparticles at pH 7.4: (**A**) zero-order, (**B**) first-order, (**C**) Korsmeyer--Peppas and (**D**) Higuchi model.**Abbreviations:** OGEO-CSNPs, *Ocimum gratissimum* essential oil-loaded chitosan nanoparticles; OGEO-TMCNPs, *Ocimum gratissimum* essential oil-loaded trimethyl chitosan nanoparticles.Table 5Kinetic Data Of OGEOO Release From Chitosan And Trimethyl Chitosan Nanoparticles In Different Physiological pH Mediums (ph 3.0 And pH 7.4)SamplesZero-OrderFirst-OrderKorsmeyer-PeppasHiguchir^2^K~0~r^2^K~1~r^2^K~KP~r^2^K~H~OGEO-CSNPs (pH 3.0)0.7921.6570.7721.7460.7921.0310.5651.569OGEO-TMCNPs (pH 3.0)0.7491.5960.6241.6680.7490.9830.7491.596OGEO-CSNPs (pH 7.4)0.6991.2890.6611.3200.00140.8610.3711.200OGEO-TMCNPs (pH 7.4)0.5571.2310.3981.1420.5570.9810.0011.143[^3]

DPPH Radical Scavenging Activity Assay {#S0003-S2006}
--------------------------------------

The antioxidant activity of compounds in line with assertions by previous studies is evaluated activity after 30 mins exposure of the compound to DPPH solution.[@CIT0050] However, Kamimura et al suggests that antioxidant activity is likely to continue over a longer period due to the unpredictable oxidation kinetics of different compounds over time.[@CIT0051]

At the initial stages (1--5 h), the antioxidant property of free OGEO was higher (*P* \< 0.05) compared to both the OGEO-MeOH and the nanoparticles. Free OGEO reached consistency after 10 h of exposure time. Even after 75 h, CSNPs and TMCNPs scavenging ability never reached consistency ([Figure 10](#F0010){ref-type="fig"}). The higher antioxidant activity of OGEO-encapsulated TMCNPs and CSNPs is attributed to the synergistic effort between OGEOs, TMCNPs, and CSNPs. The findings of this study are in agreement with the results of Zhang et al, which note that even at low concentrations, TMC shows high antioxidant activity, with a scavenging rate up to 95% higher than CS.[@CIT0052] Figure 10DPPH scavenging activity assay of *O. gratissimum* EOs, methanolic extracts, chitosan and N, N, N-trimethyl chitosan nanoparticles, and EO-loaded chitosan and N, N, N-trimethyl chitosan nanoparticles. (Bars represent means ± standard deviations).**Abbreviations:** OGEO, *Ocimum gratissimum* essential oils; OG-MeOH, *Ocimum gratissimum* methanolic extract; CSNPs, chitosan nanoparticles; TMCNPs, trimethyl chitosan nanoparticles.

Antibacterial Activity Of O. Gratissimum, Methanolic Extract, EOs, And EO-Loaded Nanoparticles {#S0003-S2007}
----------------------------------------------------------------------------------------------

[Figure 11](#F0011){ref-type="fig"} presents the antibacterial activity of the free OGEO and OGEO-MeOH as well as the OGEO-loaded nanoparticles. Based on the results, the antibacterial activity of OGEOs, OGEO-MeOH, CSNPs, TMCNPs, OGEO-CSNPs and OGEO-TMCNPs at respective MBC values of 150, 150, 200, 100, 60 and 40 (mg mL^−1^), respectively, exhibited considerable antibacterial activity on agar plates. Notably, OGEO-TMCNPs showed the highest (*P* \< 0.05) zone of inhibition ([Figure 12](#F0012){ref-type="fig"}). The enhanced antibacterial activity of the OGEO-TMCNPs is both the contribution of OGEO and TMCNPs, with TMCNPs enhancing the permeability across the microbial cell wall.[@CIT0053]

The results of the present study are in line with previous studies on the antibacterial properties of EOs against foodborne pathogens such as *S. typhimurium, E. coli*, and *Listeria monocytogens*.[@CIT0015],[@CIT0054] However, complete clarity on the antibacterial mode of action of nanoparticles of chitosan and its derivatives remain elusive. Notably, some studies have speculated that the antibacterial activity of nanoparticles of CS and their derivatives are the result of cell porousness and interactions between the NH~2~ group in CS and the electromagnetic charge on the cell wall of bacteria.[@CIT0047] The antibacterial activity of CS nanoparticles is also due to the disruption of the cytoplasm due to the penetration of CSNPs through the microbial cell wall.[@CIT0055] Figure 11The zones of inhibition for OGEO-loaded nanoparticles compared with antibiotics: (**A**) OGEO-CSNPs, (**B**) OGEO-TMCNPs, (**C**) ampicillin, and (**D**) chloramphenicol.**Abbreviations:** OGEO, *Ocimum gratissimum* essential oils; CSNPs, chitosan nanoparticles; TMCNPs, trimethyl chitosan nanoparticles. Figure 12Antimicrobial disc diffusion results for *O. gratissimum* EOs, methanolic extracts, and nanoparticles. (Columns and bars represent means ± standard deviation) **\* -** the antibacterial statistical difference (*P* ≤ 0.05) between controls (ampicillin and chloramphenicol) and *O. gratissimum* methanolic extract, EOs and nanoparticles.**Abbreviations:** OGEO, *Ocimum gratissimum* essential oils; OG-MeOH, *Ocimum gratissimum* methanolic extract; CSNPs, chitosan nanoparticles; TMCNPs, trimethyl chitosan nanoparticles.

Antiproliferative Activity Of O. Gratissimum, Methanolic Extract, EOs And EO-Loaded Nanoparticles {#S0003-S2008}
-------------------------------------------------------------------------------------------------

The cell viability and antiproliferation of a strongly metastatic breast cancer cell line (MDA-MB-231 breast cancer cells) after 48 h treatment with OGEO, OG-MeOH and the synthesised CS and TMC nanoparticles at various concentrations (0--100 µg mL^−1^) are represented in [Figure 13](#F0013){ref-type="fig"}. An exclusion assay with trypan blue dye revealed that the viability of the cells decreased with a corresponding increase in drug concentration. The results also indicated that OGEO-TMCNPs significantly inhibited the viability of the cancer cell line at much lower concentrations (P \< 0.05, n ≥ 3, [Figure 13A](#F0013){ref-type="fig"}) compared to treatment with free OGEO, OGEO-MeOH and the remaining nanoparticles. Pulgazhendi et al emphasised that chitosan nanoparticles penetrate the cancerous cells membrane, leading to DNA damage and defects in the genes of the cells.[@CIT0009] Furthermore, Shanmuganathan et al reported that the apoptosis of tumour cells due to therapy using nanoparticles of chitosan and its derivative is the result of the nanoparticles interfering with cell growth and metabolism.[@CIT0008] The highest concentration (100 µg mL^−1^) for OGEO, OGEO-MeOH, CSNPs, TMCNPs, OGEO-CSNPs and OGEO-TMCNPs decreased the viability of cancer cells to 44.25%, 64.19%, 63.56%, 38.53%, 77.19% and 37.44%, respectively ([Figure 13B](#F0013){ref-type="fig"}). Typical phase-contrast light microscope images showing the retention of trypan blue dye by the drug-treated and non-treated (control) cancer cells are presented in [Figure 14](#F0014){ref-type="fig"}. Membrane blebs were also observed with cancer cells treated with OGEO-TMCNPs after 48 h of incubation. As suggested by Umar et al, cell membrane blebbing is an indication of cell apoptosis.[@CIT0056]

The high antiproliferation activity of OGEO-TMCNPs on MDA-MB-231 breast cancer cells compared to the remaining nanoparticles and OG extracts were likely due to the generation of oxidative stress with the cell membrane.[@CIT0053] A summary of the entire process involved in the synthesis of OGEO-loaded nanoparticles and their in vitro biomedical applications is presented in [Figure 15](#F0015){ref-type="fig"}. Figure 13Effect of treatment with free *O. gratissimum* EOs, methanolic extracts, free and OGEO-loaded chitosan and N, N, N-Trimethyl chitosan nanoparticles. (**A**) Proliferation of MDa-MB 231 cells, (**B**) viability of MDa-MB 231 cells. (Columns and bars represent means ± standard deviation) \**P* ≤ 0.05 and \*\**P* ≤ 0.01 represents the statistical difference between treatment with controls (DMEM) and *O. gratissimum* methanolic extract, EOs and nanoparticles.**Abbreviations:** OGEO, *Ocimum gratissimum* essential oils; OG-MeOH, *Ocimum gratissimum* methanolic extract; CSNPs, chitosan nanoparticles; TMCNPs, trimethyl chitosan nanoparticles. Figure 14Light microscope images (20x) of MDA-MB-231 cells treated with different concentrations of samples: (**A**) CSNPs, (**B**) TMCNPs, (**C**) OG-MeOH, (**D**) OGEOs, (**E**) OGEO-CSNPs and (**F**) OGEO-TMCNPs. The non-treated cells (control) contained only DMEM (left panel). Scale bars = 75.5 μm.**Abbreviations:** OGEO, *Ocimum gratissimum* essential oils; OG-MeOH, *Ocimum gratissimum* methanolic extract; CSNPs, chitosan nanoparticles; TMCNPs, trimethyl chitosan nanoparticles. Figure 15Summary of the optimised synthesis, characterisation and bioactivity application of OGEO-loaded chitosan and N, N, N-trimethyl chitosan nanoparticles.

Conclusion {#S0004}
==========

The bioactive components of OGEO are prone to environmental degradation due to their lipophilic nature. Moreover, the encapsulation of OGEO into CS and TMC nanoparticles requires optimisation conditions for the synthesis of nanoparticles with distinct physiochemical and bioactive properties, which were evidently carried out in this study. The synthesised OGEO-loaded CS and TMC nanoparticles revealed their potential food and medical applications due to their wide solubility at different physiological pH ranges and their bioactivity as antioxidants as well as antibacterial and anticancer agents.
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[^1]: **Notes:** ^a^Values given are averages of three replicates (n = 3) ± standard deviations. Total phenolic content average values with differing superscript letters (within columns) indicate significantly different values (*P* ≤ 0.05).

[^2]: **Notes:** Reported means (± standard deviations) derived from three replications with three samples per replication. Means within each column are followed by different superscripts are significantly different at p ≤ 0.05.

[^3]: **Notes:** Where the regression coefficient is r^2^, release rate constant for zero-order is K~0~, release rate constant for first-order is K~1~, Korsmeyer-Peppas rate constant is K~KP~ and Higuchi rate constant is K~H~.
